Medical/Pharmaceuticals
Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing
DEERFIELD, Ill., Sept. 15, 2025 /PRNewswire/ -- Over the past two decades, surgical techniques have increasingly shifted toward minimally invasive approaches, requiring adapted workflows and skillsets. At the same time, patient complexity has grown, calling for tailored strategies to support safe...
2025-09-16 06:00
1637
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
* BGE-102, an orally available, brain-penetrant NLRP3 inhibitor, was developed from a hit compound identified using HitGen's industry-leading DEL technology platform, highlighting the value of DEL to accelerate innovative drug development. * The initiation of the BGE-102 Phase 1 clinical stud...
2025-09-15 21:30
1646
LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights
Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON CITY, Tenn. and HOUSTON, Sept. 15, 2025 /PRNewswire/ -- LabConnect, a leading global provider of central laboratory services today announced plans to ...
2025-09-15 21:03
1506
EmeTerm Wearable Device Under Clinical Study at Ohio State Wexner Medical Center Shows Promise for Chronic Nausea Patients
VANCOUVER, BC, Sept. 15, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among patients suffering from chronic gastric disorders. A clinical study currently u...
2025-09-15 21:00
1304
SI GROUP TO SHOWCASE SUSTAINABLE ADDITIVE INNOVATIONS AT K 2025
Industry Leader Presents Advanced Solutions for Plastics and Rubber THE WOODLANDS, Texas, Sept. 15, 2025 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, will showcase its portfolio of ...
2025-09-15 20:30
1498
Korea reinforces biopharma leadership at Global Bio Conference 2025
SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- This is an article published in The Korea Herald: The Ministry of Food and Drug Safety on Thursday announced its successful hosting of the Global Bio Conference 2025 inSeoul last week, under the theme "Bio, Navigating Infinite Possibilities." T...
2025-09-15 20:30
1537
FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals' patents covering technology relating to coffee fru...
2025-09-15 20:00
2451
Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity
SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of RN3161 to the Australian Human Research Ethics Committee (HREC).RN3161 is a proprietary GalNAc-conjug...
2025-09-15 20:00
1818
Sunsred Launches FDA-cleared Red Light Therapy Devices for Wellness Brands Worldwide
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- Shenzhen Sunsred Technology Co., Ltd. is shaking things up in the wellness tech world with its latest lineup of red light therapy devices. As a go-toOEM/ODM red light therapy manufacturer in this space, Sunsred is meeting the huge global demand for ...
2025-09-15 19:00
1173
Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225). The trial will evaluate cadonilimab, Akeso's first-in-class P...
2025-09-15 12:11
1801
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc
Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation. MELBOURNE, Australia, Sept. 15, 2025 /PRNewswi...
2025-09-15 12:06
1385
New Data, iCARE Study: Hailie® Smartinhaler® Powers Unprecedented Medication Adherence in Patients with COPD and Asthma
Highlights: * Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. * >60% patients achieved an average two-week baseline adherence with ~4 in 10 patients reaching the critical threshold...
2025-09-15 12:05
1766
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for larg...
2025-09-15 11:53
1717
EverBridge Group and Cosmotec Forge Landmark Partnership
SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an
Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned
Subsidiary of M3, Inc.; TSE: 2413) for the Japanese market.
2025-09-15 08:00
2653
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
SINGAPORE and GUANGZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initi...
2025-09-15 08:00
1559
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101
SHANGHAI and SUZHOU, China, Sept. 14, 2025 /PRNewswire/ -- Phrontline Biopharma , a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced that the first patient has been successfully dosed in its Phase 1 clinical trial of TJ101, the com...
2025-09-15 08:00
1358
Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium
* 7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). * The newly released results, based on clinical practices at several leading hospitals inChina, offer a comprehensive overview of the efficacy and safety of NEFE...
2025-09-15 07:45
4746
WFH mobilizes global community to achieve milestone revisions to WHO EML
MONTREAL, Sept. 12, 2025 /PRNewswire/ -- A concerted effort by the World Federation of Hemophilia (WFH) and its partners has led to the World Health Organization (WHO) updating its Essential Medicines List (EML) and the Essential Medicines List for Children (EMLc) to better align the EMLs to the ...
2025-09-12 21:42
1587
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
BEIJING, Sept. 12, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious ...
2025-09-12 20:00
1940
Pulnovo Medical Receives two IDE approvals for PADN system's clinical trials with CMS coverage
SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN catheter and generator has receivedtwo Investigational Device Exemption (IDE) approvals—HDE study ap...
2025-09-12 18:23
1881
Week's Top Stories
Most Reposted
One Universal Production Group (OUP) Officially Opens, Reinforcing Its Position as Asia's Leading IP Ecosystem and Tourism Company
[Picked up by 313 media titles]
2025-12-20 09:36
Singapore Airshow 2026 Marks 10th Edition with New Frontiers in Aviation and Space
[Picked up by 308 media titles]
2025-12-18 19:41
foodpanda Strengthens Merchant Care with Record Onboarding Milestone in Asia
[Picked up by 292 media titles]
2025-12-18 17:15Synvo AI and Sobat Bisnis Group (SBG) Forge Strategic Partnership to Bring Secure, Context-Aware Enterprise AI to Indonesia and Southeast Asia
[Picked up by 291 media titles]
2025-12-16 08:00
Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology
[Picked up by 287 media titles]
2025-12-16 14:26
Most Read
Cognizant and Microsoft Expand Partnership to Advance AI Transformation and Frontier Firm Experiences
2025-12-18 22:00
6130
